ARQT CIK: 1787306

Arcutis Biotherapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.40
FY22:
0.44
FY23:
0.33
FY24:
0.34
FY25:
0.41
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.01
FY24:
0.01
FY25:
0.02
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.45
FY23:
0.34
FY24:
0.35
FY25:
0.43

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.04
FY23:
0.05
FY24:
0.08
FY25:
0.13
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.20
FY23:
0.21
FY24:
0.11
FY25:
0.11
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.30
FY22:
0.21
FY23:
0.09
FY24:
0.16
FY25:
0.19
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.45
FY23:
0.34
FY24:
0.35
FY25:
0.43

All amounts in billions USD Data sources:SEC EDGARTwelve Data